--- title: "000999.SZ (000999.SZ) — 相关新闻" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/000999.SZ/news.md" symbol: "000999.SZ" name: "000999.SZ" parent: "https://longbridge.com/zh-CN/quote/000999.SZ.md" datetime: "2026-03-11T15:27:54.310Z" locales: - [en](https://longbridge.com/en/quote/000999.SZ/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/000999.SZ/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/000999.SZ/news.md) --- > 支持的语言: [English](https://longbridge.com/en/quote/000999.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/000999.SZ/news.md) # 000999.SZ (000999.SZ) — 相关新闻 ### [CR MEDICAL's 2025 keywords: personnel changes, net profit decline, asset slimming](https://longbridge.com/zh-CN/news/277607714.md) *2026-03-03T10:54:23.000Z* > CR MEDICAL announced several senior management changes after two years of adjustments, while also releasing its 2025 per ### [Vice General Manager of China Resources Group, Han Song, voluntarily surrendered](https://longbridge.com/zh-CN/news/277334145.md) *2026-03-01T02:47:16.000Z* > According to the website of the Central Commission for Discipline Inspection and the National Supervisory Commission, Ha ### [China Resources Bank quietly changes its name](https://longbridge.com/zh-CN/news/277275910.md) *2026-02-28T05:44:38.000Z* > Zhuhai China Resources Bank has quietly changed its name to Guangdong China Resources Bank, without any announcement on ### [Chairman Wang Xiangming and General Manager Wang Cuijun of China Resources Group met with Chen Gang, Secretary of the Guangxi Zhuang Autonomous Region Party Committee](https://longbridge.com/zh-CN/news/277126544.md) *2026-02-27T01:35:52.000Z* > Wang Xiangming, Chairman of China Resources Group, and Wang Cuijun, General Manager, met with Chen Gang, Secretary of th ### [In the fastest declining year for traditional Chinese medicine sales, which varieties are still growing?](https://longbridge.com/zh-CN/news/276229836.md) *2026-02-18T12:49:42.000Z* > The traditional Chinese medicine market experienced a significant decline in 2025, with overall sales affected by multip ### [With a loss exceeding 10 billion and facing a delisting crisis, CR Double-Crane also failed to rescue KONKA GROUP from the quagmire](https://longbridge.com/zh-CN/news/275689865.md) *2026-02-12T02:15:02.000Z* > KONKA GROUP expects a net loss of between 12.581 billion and 15.573 billion yuan in 2025, with operating revenue declini ### [Medical Innovation ETFs see multiple stocks in the green, institutions claim the turning point for the medical device sector has arrived](https://longbridge.com/zh-CN/news/275274139.md) *2026-02-09T06:29:15.000Z* > As of February 9, 2026, the components of the CSI Medicine and Medical Device Innovation Index showed mixed performance, ### [CR Sanjiu Medical's Profit Rises Slightly in 2025; Shares Up 4%](https://longbridge.com/zh-CN/news/275263644.md) *2026-02-09T04:24:51.000Z* > CR Sanjiu Medical's Profit Rises Slightly in 2025; Shares Up 4% ### [CR Sanjiu, a subsidiary of CHINARES PHARMA, reported a net profit of 3.422 billion RMB for the year, an increase of 1.6%](https://longbridge.com/zh-CN/news/275225417.md) *2026-02-08T10:56:55.000Z* > China Resources Pharmaceutical announced that its subsidiary China Resources Sanjiu's preliminary performance for the ye ### [CR Sanjiu Posts 14.53% Revenue Growth Under China Resources Pharmaceutical Group](https://longbridge.com/zh-CN/news/275126071.md) *2026-02-06T12:37:43.000Z* > China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (CR Sanjiu), a subsidiary of China Resources Pharmaceutical Gr